Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).

Literature DB >> 7530987

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).

M Schlumberger¹, N Abdelmoumene, M J Delisle, J E Couette.

Abstract

Combinations of 5-fluorouracil (5-FU) and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 11 long-term stabilizations were observed. No unexpected toxicity occurred.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1995 PMID： 7530987 PMCID： PMC2033569 DOI： 10.1038/bjc.1995.73

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

11 in total

1. Chemotherapy for thyroid cancer.

Authors: P J Hoskin; C Harmer
Journal: Radiother Oncol Date: 1987-11 Impact factor: 6.280

2. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.

Authors: L T Wu; S D Averbuch; D W Ball; A de Bustros; S B Baylin; W P McGuire
Journal: Cancer Date: 1994-01-15 Impact factor: 6.860

3. Reporting results of cancer treatment.

Authors: A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal: Cancer Date: 1981-01-01 Impact factor: 6.860

4. Therapy of malignant APUD cell tumors. Effectiveness of DTIC.

Authors: A Kessinger; J F Foley; H M Lemon
Journal: Cancer Date: 1983-03-01 Impact factor: 6.860

5. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

Authors: K Shimaoka; D A Schoenfeld; W D DeWys; R H Creech; R DeConti
Journal: Cancer Date: 1985-11-01 Impact factor: 6.860

6. Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil.

Authors: S R Petursson
Journal: Cancer Date: 1988-11-01 Impact factor: 6.860

7. Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy.

Authors: M Husain; R N Alsever; J P Lock; W F George; F H Katz
Journal: Horm Res Date: 1978

8. Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotide.

Authors: C Mahler; J Verhelst; M de Longueville; A Harris
Journal: Clin Endocrinol (Oxf) Date: 1990-08 Impact factor: 3.478

9. Doxorubicin plus cisplatin in the treatment of apudomas.

Authors: K S Sridhar; J F Holland; J C Brown; J M Cohen; T Ohnuma
Journal: Cancer Date: 1985-06-01 Impact factor: 6.860

10. Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy.

Authors: J P Droz; M Schlumberger; P Rougier; M Ghosn; P Gardet; C Parmentier
Journal: Tumori Date: 1990-10-31

19 in total

1. Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.

Authors: Elaine T Lam; Matthew D Ringel; Richard T Kloos; Thomas W Prior; Michael V Knopp; Jiachao Liang; Steffen Sammet; Nathan C Hall; Paul E Wakely; Vasyl V Vasko; Motoyasu Saji; Pamela J Snyder; Lai Wei; Daria Arbogast; Minden Collamore; John J Wright; Jeffrey F Moley; Miguel A Villalona-Calero; Manisha H Shah
Journal: J Clin Oncol Date: 2010-04-05 Impact factor: 44.544

2. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

Authors: Keith C Bible; Vera J Suman; Julian R Molina; Robert C Smallridge; William J Maples; Michael E Menefee; Joseph Rubin; Nina Karlin; Kostandinos Sideras; John C Morris; Bryan McIver; Ian Hay; Vahab Fatourechi; Jill K Burton; Kevin P Webster; Carolyn Bieber; Anne M Traynor; Patrick J Flynn; Boon Cher Goh; Crescent R Isham; Pamela Harris; Charles Erlichman
Journal: J Clin Endocrinol Metab Date: 2014-02-25 Impact factor: 5.958

3. Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.

Authors: Mackenzie Cook; Xiao-Min Yu; Herbert Chen
Journal: Am J Transl Res Date: 2010-02-10 Impact factor: 4.060

4. 2012 European thyroid association guidelines for metastatic medullary thyroid cancer.

Authors: M Schlumberger; L Bastholt; H Dralle; B Jarzab; F Pacini; J W A Smit
Journal: Eur Thyroid J Date: 2012-03-28

Review 5. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

Authors: Samuel A Wells; Furio Pacini; Bruce G Robinson; Massimo Santoro
Journal: J Clin Endocrinol Metab Date: 2013-06-06 Impact factor: 5.958

Review 6. Medullary thyroid cancer.

Authors: E Kebebew; O H Clark
Journal: Curr Treat Options Oncol Date: 2000-10